Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma
Objective: Immune checkpoint inhibitors (ICI) can cause endocrine adverse events. However, endocrine adverse events (AEs). However, endocrine AEs could be related to better treatment outcomes. Our aim was to investigate whether this holds true in a real-world setting of metastatic melanoma patients....
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Bioscientifica
2022-02-01
|
| Serie: | Endocrine Connections |
| Soggetti: | |
| Accesso online: | https://ec.bioscientifica.com/view/journals/ec/11/2/EC-21-0562.xml |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|